Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
All content for Oncology Unscripted is the property of Katie Coleman, Julie Johnson, Matt Spraker and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker discuss Julie and Katie's recent trip to ASCO 2023. Here are some things that were discussed during the show: Katie's Twitter thread on ASCO 2023Info on ASCO's Patient Advocacy MembershipSARC TrialsASCO VoicesOncology Unscripted is a Photon Media production. Intro and Outro music by Emmy-award winning artist Lucas Cantor Santiago. Additiona...
Oncology Unscripted
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
